Therapeutic cloning to become a reality for Britain

The potential therapeutic benefits of research on human embryos areenormous and outweigh the ethical and safety concerns, the UKgovernment decided this week.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON, August 18. A mixture of horror and excitement greeted the British government's decision this week to allow stem cell research and therapeutic cloning. For most scientists, the risk–benefit balance is clearly weighted in favour of such research, and the decision heralds a new era of therapeutic possibilities. But for many people in Britain it smacks of eugenics and meddling with the sanctity of life. So what is all the fuss about?

On Wednesday Tony Blair's government endorsed the conclusions of an expert committee led by Liam Donaldson, the chief medical officer, that embryonic stem cells — primordial cells that can differentiate into any mature cell type given the right conditions — have "enormous potential" to create new forms of treatment for currently incurable diseases. At present, research on human embryos up to 14 days old is permitted for a handful of specific purposes related to infertility. Animal studies, mainly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Joanna Lyford

    This person does not yet have a bio.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

BIOVECTRA

BIOVECTRA is Honored with 2025 CDMO Leadership Award for Biologics

Sino Logo

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo